1. Home
  2. KLXE vs HOWL Comparison

KLXE vs HOWL Comparison

Compare KLXE & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • HOWL
  • Stock Information
  • Founded
  • KLXE 2018
  • HOWL 2017
  • Country
  • KLXE United States
  • HOWL United States
  • Employees
  • KLXE N/A
  • HOWL N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • HOWL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • HOWL Health Care
  • Exchange
  • KLXE Nasdaq
  • HOWL Nasdaq
  • Market Cap
  • KLXE 89.2M
  • HOWL 87.4M
  • IPO Year
  • KLXE N/A
  • HOWL 2021
  • Fundamental
  • Price
  • KLXE $4.80
  • HOWL $1.28
  • Analyst Decision
  • KLXE Hold
  • HOWL Strong Buy
  • Analyst Count
  • KLXE 1
  • HOWL 2
  • Target Price
  • KLXE $4.50
  • HOWL $9.50
  • AVG Volume (30 Days)
  • KLXE 191.8K
  • HOWL 232.6K
  • Earning Date
  • KLXE 03-05-2025
  • HOWL 03-06-2025
  • Dividend Yield
  • KLXE N/A
  • HOWL N/A
  • EPS Growth
  • KLXE N/A
  • HOWL N/A
  • EPS
  • KLXE N/A
  • HOWL N/A
  • Revenue
  • KLXE $738,000,000.00
  • HOWL $3,386,000.00
  • Revenue This Year
  • KLXE N/A
  • HOWL N/A
  • Revenue Next Year
  • KLXE $4.79
  • HOWL $34.17
  • P/E Ratio
  • KLXE N/A
  • HOWL N/A
  • Revenue Growth
  • KLXE N/A
  • HOWL N/A
  • 52 Week Low
  • KLXE $4.18
  • HOWL $1.26
  • 52 Week High
  • KLXE $9.80
  • HOWL $8.19
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 36.20
  • HOWL 41.40
  • Support Level
  • KLXE $4.51
  • HOWL $1.26
  • Resistance Level
  • KLXE $6.16
  • HOWL $1.45
  • Average True Range (ATR)
  • KLXE 0.43
  • HOWL 0.09
  • MACD
  • KLXE -0.18
  • HOWL 0.02
  • Stochastic Oscillator
  • KLXE 4.75
  • HOWL 45.45

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: